Free Trial

SAB Biotherapeutics (SABSW) SEC Filings & 10K Form

$0.08 -0.05 (-40.30%)
As of 01/14/2025 03:49 PM Eastern

Recent SAB Biotherapeutics SEC Filings

DateFilerForm TypeView
12/31/2024
4:49 PM
Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:00 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/09/2024
7:21 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:15 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:30 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
7:00 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:30 PM
Giberson Scott (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Link David Charles (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
HAMILTON CHRISTINE E (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Lucera Erick (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SKYLER JAY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
Polvino William James (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Spragens Jeffrey G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:29 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
6:30 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:00 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SKYLER JAY S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
4:15 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
8:35 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:50 PM
Bausch Christoph Lawrence (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:55 PM
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sullivan Eddie Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:40 PM
Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:02 AM
RTW INVESTMENTS, LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
Form SC 13G
02/14/2024
5:28 AM
Radcliffe Capital Management, L.P. (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
Form SC 13G/A
02/02/2024
6:53 AM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:00 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 424B5
01/25/2024
4:00 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:21 PM
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SABSW) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners